Christopher J. Molloy

3.8k citations

60 papers · 2.8k indexed · h-index 29

Molecular Biology top 5%
Oncology top 5%
Cardiology and Cardiovascular Medicine top 5%
Cell Biology top 5%
Immunology top 10%

Co-authors: David S. Taylor Timothy P. Fleming H. Wéber Stuart A. Aaronson Donald P. Bottaro W. Wayt Gibbs Mark S. Marshall Pier Paolo Di Fiore
Topics: Skin and Cellular Biology Research (8 papers)Protein Kinase Regulation and GTPase Signaling (8 papers)Cancer-related Molecular Pathways (7 papers)
Cited by: Immunology and Allergy Oncology Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Germany Australia

In The Last Decade

Christopher J. Molloy

60 papers receiving 2.7k citations

Peers

Countries citing papers authored by Christopher J. Molloy

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Molloy more than expected).

Fields of papers citing papers by Christopher J. Molloy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Molloy. The network helps show where Christopher J. Molloy may publish in the future.

Co-authorship network of co-authors of Christopher J. Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Molloy. A scholar is included among the top collaborators of Christopher J. Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Molloy. Christopher J. Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells 2024 ·British Journal of Cancer ·Esha T. Shah,Christopher J. Molloy,(unknown),Thomas Kryza,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),James Monkman,Emma Bolderson,Arutha Kulasinghe,Yaowu He,Brian Gabrielli,John D. Hooper,Derek J. Richard,Kenneth J. O’Byrne,Mark N. Adams	8
2	Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer 2021 ·Frontiers in Oncology ·(unknown),Keyur A. Dave,(unknown),(unknown),(unknown),(unknown),Christopher J. Molloy,Neha S. Gandhi,Eric D. Boittier,Connor O’Leary,Esha T. Shah,Emma Bolderson,Anne‐Marie Baird,Derek J. Richard,Kenneth J. O’Byrne,Mark N. Adams	6
3	Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy 2021 ·Communications Biology ·(unknown),Neha S. Gandhi,(unknown),Esha T. Shah,Eric D. Boittier,Pascal H. G. Duijf,Christopher J. Molloy,Joshua T. Burgess,(unknown),Emma Bolderson,Amila Suraweera,Derek J. Richard,Kenneth J. O’Byrne,Mark N. Adams	14
4	Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,Carl L. Manthey,Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Renée L. DesJarlais,Shelley K. Ballentine,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Robert R. Donatelli,Edward J. Yurkow,Zhou Zhao,Mark R. Player,Bruce E. Tomczuk	3
5	Pharmacokinetic and Pharmacodynamic Modeling of Pegylated Thrombopoietin Mimetic Peptide (PEG‐TPOm) After Single Intravenous Dose Administration in Healthy Subjects 2009 ·The Journal of Clinical Pharmacology ·Mahesh N. Samtani,Juan José Pérez Ruixo,Kathryn H. Brown,(unknown),Christopher J. Molloy	27
6	Structure-based optimization of a potent class of arylamide FMS inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Shelley K. Ballentine,Renée L. DesJarlais,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Carl R. Illig	26
7	Discovery of novel FMS kinase inhibitors as anti-inflammatory agents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,(unknown),Mark J. Wall,Kenneth J. Wilson,Shelley K. Ballentine,Matthias Rudolph,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	40
8	A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s 2006 ·Bioorganic & Medicinal Chemistry Letters ·Nalin L. Subasinghe,Jeremy Travins,(unknown),Hui Huang,Shelley K. Ballentine,Juan Marugán,Ehab M. Khalil,(unknown),Roger Bone,Renée L. DesJarlais,Carl Crysler,(unknown),Maxwell D. Cummings,Christopher J. Molloy,Bruce E. Tomczuk	11
9	Fighting pulmonary fibrosis: new science brings new therapeutic opportunities 2004 ·Drug Discovery Today Therapeutic Strategies ·Anuk Das,Don E. Griswold,Christopher J. Molloy,Andrew A. Protter,Geoffrey J. Laurent	5
10	Design and Synthesis of 4,5-Disubstituted-thiophene-2-amidines as Potent Urokinase Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Rudolph,Carl R. Illig,Nalin L. Subasinghe,Kenneth J. Wilson,(unknown),(unknown),David Green,Christopher J. Molloy,Richard Söll,Frank Lewandowski,Marie Zhang,Roger Bone,John Spurlino,Ingrid C. Deckman,Carl L. Manthey,Celia Sharp,Diane Maguire,Bruce Grasberger,Renée L. DesJarlais,Zhou Zhao	23
11	Novel cardiovascular actions of the activins 1999 ·Journal of Endocrinology ·Christopher J. Molloy,(unknown),(unknown)	28
12	Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. 1997 ·Journal of Clinical Investigation ·John E. Pawlowski,David S. Taylor,Maria Valentine,(unknown),Pau Ferrer,Mark C. Kowala,Christopher J. Molloy	50
13	Uneven distribution of protein kinase C‐α and ‐β isozymes in human sarcomas and carcinomas 1994 ·Journal of Cellular Physiology ·Antonio Cuadrado,W. J. Issing,Timothy P. Fleming,Christopher J. Molloy	5
14	Altered expression of a mouse epidermal cytoskeletal protein is a sensitive marker for proliferation induced by tumor promoters 1992 ·Carcinogenesis ·Christopher J. Molloy,Jeffrey D. Laskin	1
15	The erb B-2 Mitogenic Signaling Pathway: Tyrosine Phosphorylation of Phospholipase C-γ and GTPase-Activating Protein Does Not Correlate with erb B-2 Mitogenic Potency 1991 ·Molecular and Cellular Biology ·Francesca Fazioli,Uh‐Hyun Kim,Sue Goo Rhee,Christopher J. Molloy,Oreste Segatto,Pier Paolo Di Fiore	21
16	Expression of protein kinase C I in NIH 3T3 cells increases its growth response to specific activators 1990 ·FEBS Letters ·(unknown),Christopher J. Molloy,Michael Pech	12
17	Keratin polypeptide expression in mouse epidermis and cultured epidermal cells 1988 ·Differentiation ·Christopher J. Molloy,J D Laskin	18
18	Epidermal Growth Factor Activates Phosphoinositide Turnover and Protein Kinase C in BALB/MK Keratinocytes 1988 ·Molecular Endocrinology ·Jorge Moscat,Christopher J. Molloy,Timothy P. Fleming,Stuart A. Aaronson	33
19	Effect of retinoid deficiency on keratin expression in mouse bladder 1988 ·Experimental and Molecular Pathology ·Christopher J. Molloy,Jeffrey D. Laskin	27
20	Effects of the chemical irritants anthralin and benzoyl peroxide on mouse skin epithelial cell protein production 1984 ·Journal of the Society of Cosmetic Chemists ·Christopher J. Molloy,Michael A. Gallo,Jeffrey D. Laskin	2

About Christopher J. Molloy

Christopher J. Molloy is a scholar working on Immunology and Allergy, Cell Biology and Oncology, having authored 60 papers that have together received 2.8k indexed citations. Recurring topics across this work include Skin and Cellular Biology Research (8 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Immunology and Allergy (199 citations), Oncology (733 citations) and Molecular Biology (1.7k citations). Christopher J. Molloy has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include David S. Taylor, Timothy P. Fleming, H. Wéber, Stuart A. Aaronson, Donald P. Bottaro, W. Wayt Gibbs, Mark S. Marshall, Pier Paolo Di Fiore, S A Aaronson and Christopher E. Turner. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact